Generation of retroviral vector for clinical studies using transient transfection.
about
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in transStructure of a Conserved Retroviral RNA Packaging Element by NMR Spectroscopy and Cryo-Electron TomographyThe intraflagellar transport protein IFT80 is required for cilia formation and osteogenesisVirus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infectionSubcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription.Progress with retroviral gene vectors.HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinantsMannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans.Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.A humanized mouse model of HPV-associated pathology driven by E7 expressionIdentification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.Regulation of beta -catenin transformation by the p300 transcriptional coactivator.The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.Human cancer gene therapy with cytokine gene-modified cells.miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells.Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.Retroviral vector production in the National Gene Vector Laboratory at Indiana University.Transplanted long-term cultured pre-BI cells expressing calpastatin are resistant to B cell receptor-induced apoptosis.Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNAAn efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking.An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus.The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.Intratubular transplantation as a strategy for establishing animal models of testicular germ cell tumours.Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis.Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination.Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate.Transient foamy virus vector production by adenovirus vectors.Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein.Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.New insights into host factor requirements for prokaryotic beta-recombinase-mediated reactions in mammalian cells.Membrane raft microdomains mediate lateral assemblies required for HIV-1 infectionGene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.One step screening of retroviral producer clones by real time quantitative PCR.Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy.miRNA-1 and miRNA-133a are involved in early commitment of pluripotent stem cells and demonstrate antagonistic roles in the regulation of cardiac differentiation.Single-step, multiple retroviral transduction of human T cells
P2860
Q24537682-285A32E2-8F16-4BD7-A79C-DCE44E45EC59Q27664955-7BD9D797-B1ED-48B3-A934-02F07358D13DQ28513239-337696DC-D482-4142-91BF-0B9ADCEDB36DQ30531089-67F9F1D1-E570-4B17-9FFE-6341FE1540C4Q30840858-9BD45BD0-3CA0-4DAD-B3E1-4D639E1730E7Q33821435-721C8493-D1C6-4808-8A07-E26DB1FA2313Q33920752-FBB07C21-9FB4-4BA6-9CB6-D9E6B976FA60Q34059564-755BC9FF-23B5-4FD4-8DAB-5024DE82704DQ34230933-9FB8C6D1-641B-4318-87B5-C49BCE79FF71Q34244510-AD9F5B56-6777-4F31-B5EE-183EEC8011C6Q34388174-4BDEA5F9-DD30-4120-BC7B-C7B9C63F009EQ34416665-B04C3CD2-ACE8-4222-B540-D867A7D56925Q35819973-B8AA2995-D089-41F9-AA28-A20E0BBC5DD0Q35848279-1D99CC3F-776C-49B7-8BDE-48474357BB1CQ35907018-FFDF8E61-22D5-45EC-A888-9AFF727F1678Q35907923-97C86329-851F-4520-AC37-0E49A7C47CE2Q35947612-49CBA61C-FDF4-4A02-9AC1-C48F4565BA1EQ36171859-4F8211E0-638A-4817-A188-71328F10F539Q36195057-CC382135-E359-4BE8-BD20-F1DBA54F42BFQ36288912-DA32739E-856F-447E-8398-E0CAA71C2F93Q36369450-238AEBFD-460F-4D4C-B609-DD337CEAB637Q37099784-389E187A-C5DD-432D-86F3-5722E21EF339Q37131958-F2C4F9F1-E133-4A25-B6EE-4338F3F90423Q39031463-B15D39BE-7497-41A0-9C7D-0DB52A924CF8Q39553970-FF3A3AEA-20F5-4402-82E3-F2DA062F8B86Q39894560-A8A5CE8A-2681-44A0-A74B-39890D3BE859Q39937255-28E6BF9E-DF41-423A-9C70-4C5DDEDAC5C0Q40032992-D9E13B38-1373-4027-AC8B-392D521B07C4Q40084435-70296CE3-4011-4A64-83DC-B04BB2C2B7F1Q40405554-960B2930-6503-44DE-BDEA-56A5FFF02D77Q40596831-CC5CF7E7-FDC3-49FA-9623-721C96432DB1Q40740227-B64D2313-2A4A-43E2-8D2A-A8B301EA2597Q40802197-204D253D-AD4C-4983-9471-BC63D8A93155Q40816493-43144E43-2F47-47AC-A45E-CF8CBC44D010Q40818759-A1AA808C-F4E1-402B-89F5-59BF4C62C033Q40878842-46748917-AB95-4BCB-8189-AD32042756BEQ40890835-20184FFD-C2FD-4922-845D-688AB6A61ACFQ45871670-8A6194FA-900A-44D9-9B3F-74060FB03E33Q47774616-A5197241-8B25-4DBC-AAFD-32530C812D83Q57351531-4CA9D8DE-B6CE-4792-B1BB-7612141C677E
P2860
Generation of retroviral vector for clinical studies using transient transfection.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Generation of retroviral vector for clinical studies using transient transfection.
@en
type
label
Generation of retroviral vector for clinical studies using transient transfection.
@en
prefLabel
Generation of retroviral vector for clinical studies using transient transfection.
@en
P2093
P1433
P1476
Generation of retroviral vector for clinical studies using transient transfection.
@en
P2093
Woffendin C
P304
P356
10.1089/10430349950019255
P577
1999-01-01T00:00:00Z